KCM
Kingdon Capital Management’s RAPT Therapeutics RAPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-575,000
| Closed | -$909K | – | 85 |
|
|
2024
Q4 | $909K | Sell |
575,000
-1,150,000
| -67% | -$1.82M | 0.13% | 56 |
|
|
2024
Q3 | $3.47M | Hold |
1,725,000
| – | – | 0.38% | 55 |
|
|
2024
Q2 | $5.26M | Buy |
1,725,000
+225,000
| +15% | +$686K | 0.56% | 49 |
|
|
2024
Q1 | $13.5M | Buy |
1,500,000
+534,172
| +55% | +$4.8M | 1.47% | 16 |
|
|
2023
Q4 | $24M | Buy |
965,828
+160,000
| +20% | +$3.98M | 3% | 3 |
|
|
2023
Q3 | $13.4M | Sell |
805,828
-194,172
| -19% | -$3.23M | 1.54% | 15 |
|
|
2023
Q2 | $18.7M | Buy |
1,000,000
+124,016
| +14% | +$2.32M | 1.77% | 10 |
|
|
2023
Q1 | $16.1M | Sell |
875,984
-4,016
| -0.5% | -$73.7K | 3.02% | 7 |
|
|
2022
Q4 | $17.4M | Buy |
880,000
+204,383
| +30% | +$4.05M | 3.47% | 8 |
|
|
2022
Q3 | $16.3M | Sell |
675,617
-347,704
| -34% | -$8.37M | 2.08% | 4 |
|
|
2022
Q2 | $18.7M | Sell |
1,023,321
-65,000
| -6% | -$1.19M | 3.17% | 4 |
|
|
2022
Q1 | $23.9M | Sell |
1,088,321
-60,000
| -5% | -$1.32M | 2.49% | 7 |
|
|
2021
Q4 | $42.2M | Hold |
1,148,321
| – | – | 4.85% | 2 |
|
|
2021
Q3 | $35.7M | Buy |
1,148,321
+377,500
| +49% | +$11.7M | 4.34% | 3 |
|
|
2021
Q2 | $24.5M | Buy |
770,821
+546,800
| +244% | +$17.4M | 2.84% | 6 |
|
|
2021
Q1 | $4.97M | Sell |
224,021
-29,587
| -12% | -$657K | 0.51% | 39 |
|
|
2020
Q4 | $5.01M | Buy |
+253,608
| New | +$5.01M | 0.54% | 33 |
|